openPR Logo
Press release

RNAI Technology Market Globally Expected to Drive Growth through 2010-2017

12-08-2017 12:35 PM CET | Health & Medicine

Press release from: Transparency Market Research

RNAI Technology Market Globally Expected to Drive Growth

Transparency Market Research’s report on the Ribonucleic Acid Interference (RNAi) technologies market offers an analytical snapshot of this highly dynamic market within the pharmaceutical industry. This report provides an overview of the global RNAi technologies scenario, before detailing each critical segment-based on type, application, and products-within this market. As well as estimating market value of the RNAi technologies market in USD million, the report provides accurate market forecasts for market size and production. In this market intelligence report, our analysts discuss in detail figures across each vertical within this market. The report further analyzes the projected RNAi technologies industry growth rate, capacity, and structure. We also provide an analytical overview of the historical data. Other important aspects, such as growth drivers and restraining factors are enumerated in this market research report.

This report is a discussion of the overall landscape of the RNAi technologies market, focusing on the competitive and regulatory environment, the value chain, and the bargaining power of key stakeholders.

Request for TOC @ https://www.transparencymarketresearch.com/rnai-technology-market.html

Overview : RNAi is a mechanism of gene regulation, and an important pathway that is used by many different organisms. Entities in the biotechnology and pharmaceutical world are taking an active interest in RNAi technology, as it is poised to substitute the existing recombinant technology in therapeutics and drug discovery.

The RNAi technologies market is witnessing numerous applications in agriculture, drug discovery, therapeutics, and medical research – specifically metabolism and functional genomics. Within the RNAi technology market, the therapeutics application segment can be further categorized as: neurology, oncology, ophthalmology, cardiology, and metabolic disorders. Based on the tools and products used for realizing Ribonucleic Acid Interference applications, the market can be classified into: libraries, software and vectors. Based on its type, RNAi technology can also be categorized as small interfering RNAi and micro RNAi.

Request for Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=141

The prospects look promising for the RNAi technologies market, especially given the anticipated double digit growth. As the market for Ribonucleic Acid Interference technologies develops, it could outperform current post-genomic-era technologies such as Recombinant DNA

Several key market players—duly backed by venture capitalists and investors—have made massive investments in applying RNAi technologies in developing oligonucleotide drugs. This industry has been a field not just for research and development, but also for numerous mergers and takeovers. Specialty companies are rapidly emerging in the RNAi technologies market, and will likely shape the future of this sector in the coming years. Among pharma giants that are looking for ways to fill their weak pipelines, many consider RNAi-based drugs as a lucrative solution for the same. Given that the RNAi technologies market is still at a nascent stage, companies are keen on earning an early-movers’ advantage.

Pre Book full report@ https://www.transparencymarketresearch.com/rnai-technology-market.html?secure=NTIxNS41&type=PB

About TMR

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact

Transparency Market Research
State Tower
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
TMR Blog: http://www.theglobalhealthnews.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release RNAI Technology Market Globally Expected to Drive Growth through 2010-2017 here

News-ID: 852095 • Views: 164

More Releases from Transparency Market Research

Impact of Outbreak of COVID-19 on Medical Education Market : Global Industry Ana …
Transparency Market Research (TMR) has published a new report on the medical education market for the period of 2019–2027. According to the report, the global medical education market was valued at nearly US$ 31 Bn in 2018, and is projected to expand at a CAGR of more than 4% from 2019 to 2027. Rise in the number of medical schools and increase in cost of medical education are the
Healthcare BI Platform Market Companies Analysis, Advancement and Precise Outloo …
In an intensely competitive healthcare business intelligence (BI) platform market, large players are aggressively focused on expanding their geographical outreach, says Transparency Market Research (TMR) in a new market intelligence report. These large players are leveraging the cloud business model to provide healthcare BI solutions that can be accessed irrespective of location. Apart from this, savvy players are entering into partnerships with hospital groups and healthcare bodies to integrate healthcare BI
Substance Abuse Treatment Market News Research Report 2024
A recent report by Transparency Market Research on the substance abuse treatment market in the U.S. states that the competitive landscape is highly fragmented. This is because around 242 companies compete against one another in it. This also makes overall competition stiff. Some of the companies that have beat competition to emerge as leading players in the market are Pfizer Inc., Alkermes Plc, GlaxoSmithKline Plc., and Purdue Pharma LP. Their
Clinical Oncology Next Generation Sequencing Market is Thriving Worldwide By Siz …
Clinical Oncology Next Generation Sequencing: Introduction Next generation sequencing for tumor and germline DNA is required for oncology screening for therapeutic application. Rise in burden of cancer increases the need for early detection of the condition to carry out the generate target therapy. Companies are investing to develop technologically advanced devices/solutions for precision detection. In 2012, Oxford Nanopore had launched the GridION sequencing platform, which can sequence a human genome in 15

All 5 Releases


More Releases for RNAi

Top Factors Driving the RNAi for Therapeutic Market
The qualitative research study conducted by HTF MI titled “Global RNAi for Therapeutic Market Size, Status and Forecast 2025” provides primary Data, surveys, Scope of the Product and vendor briefings. The market dynamic forces have been determined after conducting a detailed study of the Global RNAi for Therapeutic market. The study provides forecasts for RNAi for Therapeutic investments till 2022. RNA interference (RNAi) is a biological process in which RNA
RNAI Technology Market - Comprehensive Evaluation of Market By 2017
Transparency Market Research’s report on the Ribonucleic Acid Interference (RNAi) technologies market offers an analytical snapshot of this highly dynamic market within the pharmaceutical industry. This report provides an overview of the global RNAi technologies scenario, before detailing each critical segment-based on type, application, and products-within this market. As well as estimating market value of the RNAi technologies market in USD million, the report provides accurate market forecasts for market
Antisense and RNAi Therapeutics Market - Competitive Dynamics & Global Outlook 2 …
Global Antisense and RNAi Therapeutics Market: Overview The rising incidence of coronary artery diseases, cardiac ailments, and neurodegenerative and infectious diseases has led to the demand for antisense and RNai therapeutics. The market exhibits a strong pipeline of product and is looking forward to introduce several advancements in the RNAi drug delivery technology. These factors will act as high growth rendering drivers in the coming years. The global antisense and RNAi therapeutics
Agrow: RNAi
ReportsWorldwide has announced the addition of a new report title Agrow: RNAi to its growing collection of premium market research reports. Employed as a research tool in entomology and as a means of crop protection and pest control, RNA interference (RNAi) technology is a natural process used to ‘silence’ genes – a way of reducing or switching off the activity (or expression) of individual genes. With a major drive to tackle resistance
Global RNAi Drug Pipeline Analysis
“Global RNAi Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed based upon RNAi technology. Research report covers all the ongoing drugs being developed in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight for each drug profile in
Global RNA Interference (RNAi) Therapy Market Outlook 2018
The popularity of RNAi technology has been increasing in recent times as is has become a major component of basic research, and in drug discovery. Over the years this technology has become an integral part of the process of determining the functions of gene, in analyzing pathways, and in the validation of the target both in academia and in industry. Since discovery, RNA interference is considered to be a turning